Silvant Capital Management’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Other funds holding INSM
Silvant Capital Management's INSM Position: Q3 2026 in Review
Silvant Capital Management reduced its Insmed (INSM) stake by 4.1% in Q3 2026, selling an estimated $95.8K and leaving 18,948 shares worth $2.16M. The position accounts for 0.04% of the portfolio, ranked #140.
Silvant Capital Management first reported a position in INSM in Q2 2019 and has held it in 18 quarters since. The position peaked at $3.41M in Q4 2025. 547 funds tracked by Wall St. Rank hold INSM as of Q3 2026.
- Silvant Capital Management held 18,948 shares of Insmed worth $2.16M as of Q3 2026.
- Silvant Capital Management sold 813 Insmed shares in Q3 2026, an estimated $95.8K.
- Insmed made up 0.04% of Silvant Capital Management's portfolio in Q3 2026, its #140 holding.
- Silvant Capital Management first reported a position in Insmed in Q2 2019 and has held it in 18 quarters since.
- Silvant Capital Management's Insmed position peaked at $3.41M in Q4 2025.
- 547 funds tracked by Wall St. Rank held Insmed as of Q3 2026.
Based on Silvant Capital Management's 13F filing for Q3 2026, filed 9 Nov 2026.